The results showed that compared with corresponding normal tissues, STEAP3 was up-regulated in bladder cancer, blood cancer, brain cancer, cervix cancer, colon cancer, kidney cancer, lung cancer, ovary cancer, pancreas cancer and thyroid cancer tissues. Here, STEAP3 is linked to hematopoietic and lymphoid system neoplasm.